Invention Grant
- Patent Title: Pharmaceutical compositions
-
Application No.: US17671207Application Date: 2022-02-14
-
Publication No.: US11376243B2Publication Date: 2022-07-05
- Inventor: Magnus Brisander , Mustafa Demirbüker , Gérald Jesson , Martin Malmsten , Helene Dérand
- Applicant: XSPRAY PHARMA AB
- Applicant Address: SE Solna
- Assignee: XSPRAY PHARMA AB
- Current Assignee: XSPRAY PHARMA AB
- Current Assignee Address: SE Solna
- Agency: Merchant & Gould P.C.
- Agent Daniel R. Evans
- Priority: SE1250015-3 20120113,SE1251160-6 20121012
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61K9/00 ; A61K9/14 ; A61K9/16 ; A61K9/51 ; A61K31/437 ; A61K31/4439 ; A61K31/444 ; A61K31/4545 ; A61K31/506 ; A61K31/517 ; A61K31/5377 ; A61K47/32 ; A61K47/38
Abstract:
The present invention relates to the field of methods for providing pharmaceutical compositions comprising poorly water-soluble drugs. In particular the present invention relates to compositions comprising stable, amorphous hybrid nanoparticles, comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component, useful in pharmaceutical compositions and in therapy.
Public/Granted literature
- US20220168285A1 PHARMACEUTICAL COMPOSITIONS Public/Granted day:2022-06-02
Information query
